Real-World Patterns of Basal Insulin Use with Other Diabetes Medications Among People with Type 2 Diabetes Between 2014 and 2020.

Schapiro, David; Juneja, Rattan; Huang, Ahong; Meeks, Alexandra; Liu, Dongju; Gelsey, Felicia T; Perez-Nieves, Magaly

Schapiro, David; Juneja, Rattan; Huang, Ahong; Meeks, Alexandra; Liu, Dongju; Gelsey, Felicia T; Perez-Nieves, Magaly.

Afiliação

Schapiro D; Eli Lilly and Company, Indianapolis, IN, 46225, USA. schapiro_david@lilly.com.
Juneja R; Eli Lilly and Company, Indianapolis, IN, 46225, USA.
Huang A; Tigermed-BDM, 100 Franklin Square Dr #305, Somerset, NJ, 08873, USA.
Meeks A; Eli Lilly and Company, Indianapolis, IN, 46225, USA.
Liu D; Eli Lilly and Company, Indianapolis, IN, 46225, USA.
Gelsey FT; Eli Lilly and Company, Indianapolis, IN, 46225, USA.
Perez-Nieves M; Eli Lilly and Company, Indianapolis, IN, 46225, USA.

Diabetes Ther ; 14(7): 1157-1174, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37184630

Palavras-chave

Cardiovascular disease; GLP-1RA; Guidelines; Insulin; Renal disease; SGLT-2i; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies Idioma: En Revista: Diabetes Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google